---All---
  • ---All---
  • Accession
  • Catalog #

SIRT2 Antibody (C-term)Rabbit Monoclonal Antibody

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AJ1718b 100ul 400 ul 2-3 days $ 315.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

SIRT2 Antibody (C-term) - Product info

ApplicationWB, IF
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionQ8IXJ6
ReactivityHuman
Clone NamesEP1668Y
Calculated MW43182 Da
Gene ID 22933
Target/Specificity
A synthetic peptide corresponding to residues on the C-terminus of human SIRT2 was used as an immunogen.
Dilution
WB~~1:1000~10000
Format
50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
SIRT2 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures.

SIRT2 Antibody (C-term) - Protein Information

Name SIRT2
Synonyms SIR2L, SIR2L2
Function
NAD-dependent protein deacetylase, which deacetylates internal lysines on histone and non-histone proteins. Deacetylates 'Lys-40' of alpha-tubulin. Involved in the control of mitotic exit in the cell cycle, probably via its role in the regulation of cytoskeleton. Deacetylates PCK1, opposing proteasomal degradation Deacetylates 'Lys-310' of RELA
Cellular Location
Cytoplasm, cytoskeleton. Note=Colocalizes with microtubules
Tissue Location
Widely expressed. Highly expressed in heart, brain and skeletal muscle, while it is weakly expressed in placenta and lung. Down-regulated in many gliomas suggesting that it may act as a tumor suppressor gene in human gliomas possibly through the regulation of microtubule network

SIRT2 Antibody (C-term) - Related products

RI14877: SIRT2 predesign siRNA

AT3891a: SIRT2 Antibody (monoclonal) (M01)

AJ1718a: SIRT2 Antibody

AJ1718b: SIRT2 Antibody (C-term)

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

Silent information regulator 2 (Sir2) family of enzymes has been implicated in many cellular processes that include histone deacetylation, gene silencing, chromosomal stability, and aging. O-acetyl-ADP-ribose causes a delay/block in oocyte maturation and results in a delay/block in embryo cell division in blastomeres. It has been demonstrated that the production of O-acetyl-ADP-ribose is evolutionarily conserved among Sir2-like enzymes from yeast, Drosophila, and human. Also, endogenous yeast Sir2 complex from telomeres was shown to generate O-acetyl-ADP-ribose (1). SIRT2 is a predominantly cytoplasmic protein that colocalizes with microtubules. SIRT2 deacetylates lysine-40 of alpha-tubulin both in vitro and in vivo. Knockdown of SIRT2 via siRNA results in tubulin hyperacetylation. SIRT2 colocalizes and interacts in vivo with HDAC6, another tubulin deacetylase (2). Cytoskeleton-related protein, SIRT2 is down-regulated in gliomas, and data suggests that ectopic expression of SIRT2 in glioma cell lines led to the perturbation of the microtubule network (3).

REFERENCES

1. Borra MT, et al. J Biol Chem 277(15):12632-41, 2002.
2. North BJ, et al. Mol Cell 11(2):437-44, 2003.
3. Hiratsuka M, et al. Biochem Biophys Res Commun 309(3):558-66, 2003.